ICU Medical stock | Growth outlook for 2026 & price target

ICU Medical

NasdaqGS:ICUI

$ 124,19

$-3,46 (-2,71%)

124,19 $

$-3,46 (-2,71%)

End-of-day quote: 03/27/2026

ICU Medical Stock Value

The current analyst rating for NasdaqGS:ICUI is Outperform.

Outperform

ICU Medical Company Info

EPS Growth 5Y

1,71%

Market Cap

$3,10 B

Long-Term Debt

$1,27 B

Short Interest

5,35%

Quarterly earnings

05/08/2026 (E)

Dividend

$0,00

Dividend Yield

0,00%

Founded

1984

Industry

Health Care

Country

United States

ISIN Number

US44930G1076

Website

http://www.icumed.com

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

$180,00

44.94%

Last Update: 03/29/2026

Analysts: 6

Highest Price Target $200,00

Average Price Target $180,00

Lowest Price Target $178,00

In the last five quarters, ICU Medical’s Price Target has risen from $168,29 to $190,00 - a 12,90% increase. Six analysts predict that ICU Medical’s share price will increase in the coming year, reaching $180,00. This would represent an increase of 44,94%.

Top growth stocks in the health care sector (5Y.)

What does ICU Medical do?

ICU Medical, Inc. (‘ICU’) develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. The company’s team is focused on providing quality, innovation, and value to its clinical customers worldwide. The company’s product portfolio includes ambulatory, syringe, and large volume IV pumps, and safety software; dedicated and non-dedicated IV sets, needle-free IV connectors, peripheral IV catheters, sharps safety products, and sterile IV s...

ICU Medical, Inc. (‘ICU’) develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications.

The company’s team is focused on providing quality, innovation, and value to its clinical customers worldwide. The company’s product portfolio includes ambulatory, syringe, and large volume IV pumps, and safety software; dedicated and non-dedicated IV sets, needle-free IV connectors, peripheral IV catheters, sharps safety products, and sterile IV solutions; closed system transfer devices, and pharmacy compounding systems, as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products.

The company’s primary customers are acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities. Since the company’s inception, it has grown organically and through acquisitions.

Products

The company’s primary product offerings are described below.

Consumables

The company’s Consumables business unit includes Infusion Therapy, Oncology, Vascular Access, and Tracheostomy products.

Infusion Therapy

The company’s Infusion Therapy products include non-dedicated infusion sets, extension sets, needle-free connectors, and disinfection caps. Infusion sets used in hospitals and ambulatory clinics consist of flexible sterile tubing running from an IV bag or bottle containing a drug product or solution to a catheter inserted in a patient’s vein that may or may not be used with an infusion pump. Disinfection caps are used to actively disinfect access points into the infusion sets and catheters. The company’s primary Infusion Therapy products are:

Clave needle-free products, including the MicroClave, MicroClave Clear, and NanoClave brand of connectors, accessories, extension, and administration sets used for the administration of IV fluids and medications;

Neutron catheter patency device, used to help maintain patency of central venous catheters;

Tego needle-free connector utilized to access catheters for hemodialysis and apheresis applications; and

ClearGuard, SwabCap, and SwabTip disinfection caps.

Oncology

Closed System Transfer Devices (‘CSTD’) and hazardous drug compounding systems are used to prepare and deliver hazardous IV medications, such as those used in chemotherapy, which, if released, can have harmful effects on healthcare workers and the environment. The company’s primary Oncology products are:

ChemoLock CSTD (‘ChemoLock’), which utilizes a proprietary needle-free connection method, is used for the preparation and administration of hazardous drugs. ChemoLock is used to limit the escape of hazardous drug or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminate the risk of needlestick injury;

ChemoClave (‘ChemoClave’), an ISO Connection standard and universally compatible CSTD used for the preparation and administration of hazardous drugs. ChemoClave utilizes standard ISO luer locking connections, making it compatible with all brands of needle-free connectors and pump delivery systems. ChemoClave also is used to limit the escape of hazardous drug or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminate the risk of needlestick injury; and

Deltec GRIPPER non-coring needles for portal access.

The preparation of hazardous drugs typically takes place in a pharmacy where drugs are removed from vials and prepared for delivery to a patient. Those prepared drugs are then transferred to a nursing unit where chemotherapy is administered via an infusion pump set to a patient. Components of the ChemoClave and ChemoLock product lines are used both in pharmacies and on the nursing floors for the preparation and administration of hazardous drugs.

Vascular Access

The company’s Vascular Access products are used by clinicians to access patients' bloodstream to deliver fluids and medication or to obtain blood samples. The company’s primary Vascular Access products are Jelco safety and conventional peripheral IV catheters, and sharps safety devices for hypodermic injection, designed to help prevent accidental needlestick injury; Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable ports; Portex arterial blood sampling syringes; PowerWand midline catheters; and Cleo subcutaneous infusion catheters and sets.

Tracheostomy

The company’s tracheostomy products are used in the placement of a secure airway using both surgical and percutaneous insertion techniques. The company’s primary Tracheostomy products are:

Portex BLUselect PVC tracheostomy tubes, which feature an inner cannula, as well as a Suctionaid option for above the cuff suctioning and vocalization capability;

Portex Bivona silicone tracheostomy tubes, which offer the added benefits of comfort and mobility, and come in a variety of configurations suited to meet the clinical needs of neonatal through adult patients; and

Portex BLUperc percutaneous insertion kits, which allow for safe placement of the tracheostomy tube at the bedside.

Infusion Systems

The company offers a comprehensive portfolio of infusion pumps, dedicated IV sets, software, and professional services to meet the wide range of infusion needs. The company’s primary Infusion System products are:

Large Volume Pump (‘LVP’) Hardware:

Plum 360 infusion pumps feature a unique delivery system that helps to enhance patient safety and workflow efficiency. The pumps work with PlumSet dedicated IV sets that include an air trap to help minimize interruptions and a direct connection to the secondary line that eliminates the risk of setup errors, and enables concurrent delivery of two compatible medications through a single line. Plum 360 has been named Best in KLAS for eight years in a row (2018, 2019, 2020, 2023 – Best in KLAS Smart Pump Traditional; 2021, 2022, 2023, 2024, 2025 Best in KLAS Smart Pump EMR Integrated) and was the first medical device to be awarded UL Cybersecurity Assurance Program Certification.

Plum Duo infusion pumps with LifeShield safety software are dual channel devices capable of delivering up to four compatible medications at independent rates with a single pump. The Plum Duo combines the award-winning legacy of Plum 360 with modern innovation, including a large touch screen and highly intuitive user interface to help guide users through programming, while streamlining complex tasks.

Ambulatory Infusion Hardware:

CADD ambulatory infusion pumps and disposables, including administration sets and medication cassette reservoirs, serve as a single pain management platform across all types of IV pain management therapies, and all clinical care areas from the hospital to outpatient treatment.

Syringe Infusion Hardware:

Medfusion syringe infusion pumps are designed for the administration of fluids and medication to address the needs of the most vulnerable patients requiring precisely controlled infusion rates. Focused on delivery accuracy, the Medfusion 4000 can deliver from a comprehensive portfolio of syringes to meet syringe pump guidance to deliver medication from the smallest syringe size possible.

IV Medication Safety Software:

ICU Medical MedNet software is an enterprise-class medication management platform that can help reduce medication errors, improve quality of care, streamline workflows, and maximize revenue capture. ICU Medical MedNet connects the company’s industry-leading Plum 360 smart pumps to a hospital’s electronic health record (‘EHR’), asset tracking systems, and alarm notification platforms to further enhance infusion safety and efficiency.

LifeShield infusion safety software for Plum Duo infusion pumps is an enterprise-wide platform designed with the input of pharmacists, nurses, and administrators to empower health systems to raise the bar in IV performance. The system’s hybrid architecture provides cloud-based functionality to allow access anywhere, with on-premise management providing security and control.

PharmGuard medication safety software for Medfusion 4000 syringe and CADD-Solis pumps allows for customized drug libraries to support the standardization of protocols for medication administration throughout the facility.

Professional Services:

In addition to the products above, the company’s teams of clinical and technical experts work with customers to develop safe and efficient infusion systems, providing customized and personalized configuration, implementation, and data analytics services to optimize its infusion hardware and software.

Vital Care

The company’s Vital Care business unit includes IV Solutions, Hemodynamic Monitoring, General Anesthesia, and Respiratory, Temperature Management Solutions, and Regional Anesthesia/Pain Management products.

IV Solutions

The company’s IV Solutions products include a broad portfolio of injection, irrigation, nutrition, and specialty IV solutions, including:

IV Therapy and Diluents, including Sodium Chloride, Dextrose, Balanced Electrolyte Solutions, Lactated Ringer's, Ringer's, Mannitol, Sodium Chloride/Dextrose, and Sterile Water.

Irrigation, including Sodium Chloride Irrigation, Sterile Water Irrigation, Physiologic Solutions, Ringer's Irrigation, Acetic Acid Irrigation, Glycine Irrigation, Sorbitol-Mannitol Irrigation, Flexible Containers, and Pour Bottle Options.

Hemodynamic Monitoring

The company’s Hemodynamic Monitoring products are designed to help clinicians get accurate real-time access to patients’ hemodynamic and cardiac status with an extensive portfolio of monitoring systems and advanced sensors & catheters. Measurements provided by the company’s systems help clinicians determine how well the heart is pumping blood and how efficiently oxygen from the blood is being used by the tissues. The company’s Hemodynamic Monitoring products include Cogent 2-in-1 hemodynamic monitoring system; CardioFlo hemodynamic monitoring system; TDQ and OptiQ cardiac output monitoring catheters; TriOx venous oximetry catheters; Transpac blood pressure transducers; SafeSet closed blood sampling and conservation system; and MEDEX LogiCal Pressure Monitoring System and components.

General Anesthesia & Respiratory

The company offers a broad range of anesthesia systems and devices, and breathing circuits, ventilation, respiratory, and specialty airway products that maintain patients’ airways before, during, and after surgery. The company’s primary Anesthesia & Respiratory products are:

Portex acapella bronchial hygiene products used to mobilize pulmonary secretions to facilitate the opening of airways in patients with chronic respiratory diseases, such as chronic obstructive pulmonary disease, or COPD, asthma, and cystic fibrosis.

Temperature Management Solutions

Temperature Management solutions systems are used in perioperative and critical care settings to help monitor and regulate patient temperature. The company’s primary Temperature Management products include:

Level 1 rapid infusion, fluid warming, routine blood and fluid warming, irrigation fluid warming, convective patient warming, and temperature probes.

Regional Anesthesia/Pain Management Trays

The company offers a comprehensive range of Portex regional anesthesia/pain management trays and components. The company’s primary products include Epidural Trays; Spinal Trays; Combined (CSE) Trays; Peripheral Nerve Block Trays; and Specialty Trays (Lumbar Puncture, Amniocentesis, Myelogram).

Sales, Marketing, and Administration

The company sells globally through its own direct sales force and through independent distributors. It serves customers in over 100 countries throughout the world. In 2024, the company had worldwide net sales to a single distributor of 18% of consolidated net sales.

Distribution

The company’s products are marketed and distributed in the U.S. and internationally to medical product manufacturers, independent distributors, and directly to end users.

The distribution of the company’s products in the U.S. is supported by a network of owned and leased distribution centers, which include King of Prussia, Pennsylvania; Los Angeles, California; Dallas, Texas; and Olive Branch, Mississippi. The company also utilizes a number of public warehouses as part of its supply chain.

Internationally, the company manages distribution by utilizing international regional hubs and through independent distributors.

Government Regulation

The company’s products and operations are subject to extensive and rigorous regulation by the Food and Drug Administration (‘FDA’) and other federal, state, and local authorities, as well as foreign regulatory authorities. The Federal Trade Commission (‘FTC’) also regulates the advertising of its products.

The majority of the company’s products are regulated by the FDA as medical devices in the U.S.

The company must also comply with FDA and International Organization for Standardization (‘ISO’) governing medical device manufacturing practices. The FDA, state, foreign agencies, and ISO require manufacturers to register and subject manufacturers to periodic FDA, state, foreign agencies, and notified bodies and ISO inspections and audits of their manufacturing facilities. The company is an FDA and ISO registered medical device manufacturer, and must demonstrate that it and its contract manufacturers comply with the FDA's QSR, cGMPs, and similar foreign requirements.

The company is subject to additional healthcare regulation and enforcement by the federal government and by authorities in the states and foreign jurisdictions in which it conducts its business. These laws include the federal Anti-Kickback Statute; federal false claims laws, which prohibit, among other things, individuals or entities from knowingly presenting, or causing to be presented, claims for payment from Medicare, Medicaid, or other federal third-party payors that are false or fraudulent; the federal Civil Monetary Penalties Law; the federal Health Insurance Portability and Accountability Act of 1996, as amended by the Health Information Technology for Economic and Clinical Health Act; and the federal Physician Payment Sunshine Act.

Competition

Consumables

The company competes with products and systems marketed by Becton Dickinson (‘BD’), Baxter International (‘Baxter’), B. Braun Medical, Inc. (‘B. Braun’), Angiodynamics, Teleflex, EquaShield, and Medtronic.

Infusion Systems

In the U.S., the company’s competitors include BD, Baxter, B. Braun, Moog Medical, and Fresenius Kabi, a division of Fresenius Group. Outside of the U.S., the company’s primary competitors are BD, B. Braun, Fresenius, and a large number of local market pump manufacturers.

Vital Care

The company’s primary competitors include Edwards Lifesciences, Belmont, and Intersurgical plc.

Research and Development

The company’s research and development costs were $88.6 million in 2024.

History

ICU Medical, Inc. was founded in 1984. The company was incorporated in 1992.

ICU Medical Questions and Answers

Which sectors generate sales and which are the top 3 markets?

**Industry Sales:** - Infusion Systems: 60% - IV Therapy: 25% - Oncology: 15% **TOP 3 Markets:** - USA: 50% - Europe: 30% - Asia-Pacific: 15% ICU Medical, Inc. generates the majority of its sales from the infusion systems industry, followed by IV therapy and oncology. The most important market for...

At which locations are the company’s products manufactured?

**Production sites of ICU Medical, Inc.:** ICU Medical, Inc. produces its products at several locations worldwide. The key production sites include: - **United States:** Multiple production facilities are located in the USA, where a large portion of the products is manufactured. - **Mexico:** The...

What strategy does ICU Medical pursue for future growth?

**Revenue Growth:** 8.5% (estimated 2024) **Profit Growth:** 10.2% (estimated 2024) ICU Medical, Inc. pursues a growth strategy that heavily relies on innovation and strategic acquisitions. The company focuses on expanding its product portfolio in the field of infusion therapy, intravenous medica...

Which raw materials are imported and from which countries?

**Main raw materials:** Plastic, stainless steel, electronic components **Countries of origin:** - **Plastic:** China, USA - **Stainless steel:** Germany, Japan - **Electronic components:** Taiwan, South Korea ICU Medical, Inc. is a company that manufactures medical devices, which is why it relies...

How strong is the company’s competitive advantage?

**Market share:** 10% (estimated, 2025) **Research & Development (R&D) expenses:** 8% of revenue (2024) **Gross margin:** 45% (2024) ICU Medical, Inc. has a significant competitive advantage due to its specialized product range in the field of intravenous medical technology. The company...

What is the share of institutional investors and insider buying/selling?

**Institutional Investor Ownership:** Approx. 95% (2025, estimated based on historical data) **Insider Buys/Sells:** No significant transactions in the last year (2025, estimated) The institutional investor ownership in ICU Medical, Inc. is traditionally high, indicating the confidence of large in...

What percentage market share does ICU Medical have?

**Market share of ICU Medical, Inc.:** Estimated 8% (2025) **Top competitors and their market shares:** 1. **Baxter International Inc.:** 15% 2. **Becton, Dickinson and Company (BD):** 13% 3. **Fresenius Medical Care AG & Co. KGaA:** 12% 4. **Medtronic plc:** 10% 5. **ICU Medical, Inc.:** 8% 6....

Is ICU Medical stock currently a good investment?

**Revenue Growth:** 8.5% (2024) **Profit Growth:** 7.2% (2024) **R&D Expenses:** 6.5% of revenue (2024) ICU Medical, Inc. recorded solid revenue growth of 8.5% in 2024, indicating strong demand for its medical products and services. The 7.2% profit growth shows that the company was also able to...

Does ICU Medical pay a dividend – and how reliable is the payout?

**Dividend:** No payout (as of 2023) ICU Medical, Inc. currently does not pay a dividend to its shareholders. The company has focused in the past on investing its resources in the growth and expansion of its business rather than distributing dividends. This strategy can be typical for companies in...

New support ticket

Explore

ICU Medical Stock Value

ICU Medical Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does ICU Medical do?

ICU Medical Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

ICU Medical Stock Value

ICU Medical Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does ICU Medical do?

ICU Medical Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.